FIELD: pharmacology.
SUBSTANCE: in formula 
(I) R1 and R2 each represents a hydrogen atom, formula -(CR4R4')-O-CO-R5, or -(CR6R6')-O-CO-OR7, or formula 
(IIa) or (IIb), R3 represents a hydrogen atom, formula -(AA)n-H, -CO-O-(CR9R9')-O-CO-R10, or -CO-O-(CR9R9')-O-CO-OR11, or formula 
(III), R4 and R4' each represents a hydrogen atom or a C1-6alkyl group, R5 is a C1-10alkyl, adamantyl or phenyl group, R6 and R6'each represents a hydrogen atom or C1-6alkyl group, R7 is a C1-10alkyl, C3-8cycloalkyl or adamantyl group, R8 is a C1-6alkyl group, R9 and R9' each represents a hydrogen atom or C1-6alkyl group, R10 is a C1-10alkyl group, R11 is a C3-8cycloalkyl group, R12 is a C1-6alkyl group, AA is an aminoacyl group and n is an integer from 1 to 3.
EFFECT: application of compounds for prevention or treatment of the diseases listed above.
17 cl, 7 tbl, 42 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
| ESTER DERIVATIVE OF 2-AMINO-BICYCLO[3,1,0]HEXANE-2,6-DICARBOXYLIC ACID | 2004 |
|
RU2409557C2 |
| DERIVATIVES OF 6-FLUOROBICYCLO[3.1.0]HEXANE | 2002 |
|
RU2315622C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
| FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | 2014 |
|
RU2704112C2 |
| NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2786722C1 |
| NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
| AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2747318C2 |
| 2-AZA-BICYCLO[3,1,0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | 2007 |
|
RU2460732C2 |
